Life sciences news

argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies

22 hours ago

Read more
ExeVir Announces Michael Garrett as New Chief Executive Officer

Tuesday November 19th 2024

Read more
Sequana Medical Announces Strong 24-Month Results from POSEIDON Study at AASLD The Liver Meeting® in San Diego; US PMA alfapump approval expected before end of Q1 2025

Tuesday November 19th 2024

Read more
ATB Therapeutics Raises €54 Million Series A Financing to Propel Innovative Antibody Payload Technology into Clinical Development

Tuesday November 19th 2024

Read more
FDA authorizes the first AI-driven MRI solution for safer Alzheimer’s treatment

Friday November 15th 2024

Read more
Plant roots change their growth pattern during ‘puberty’

Friday November 15th 2024

Read more
Scientists discover how specific E. coli bacteria drive colon cancer

Thursday November 7th 2024

Read more
Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024

Wednesday November 6th 2024

Read more
Your news here?

Become a flanders.bio member
reMYND announces positive Phase 2a clinical trial results for treatment of mild-to-moderate Alzheimer’s disease

Friday November 1st 2024

Read more
Can we protect nerve cells from dying?

Friday November 1st 2024

Read more
Resistance in Candida auris, how to tackle a deadly fungus

Wednesday October 30th 2024

Read more

More info?

Communication Coordinator